SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039333
Filing Date
2020-06-29
Accepted
2020-06-29 20:59:43
Documents
1
Period of Report
2020-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5717
  Complete submission text file 0001209191-20-039333.txt   7212
Mailing Address BAIN CAPITAL, LLC 200 CLARENDON STREET BOSTON MA 02116
Business Address
PATRICK DEVAL L (Reporting) CIK: 0001053466 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 20999728
SIC: 4512 Air Transportation, Scheduled

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations